FDA Label for Carcinosin Miasm Drops 2142
View Indications, Usage & Precautions
Carcinosin Miasm Drops 2142 Product Label
The following document was submitted to the FDA by the labeler of this product Professional Complementary Health Formulas. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
Aurum muriaticum 6X
Symphytum officinale 6X
Hekla lava 8X
Sarcolacticum acidum 15X
Asterias rubens 30X
Crotalus horridus 30X
Thuja occidentalis 30X
Secale cornutum 60X
Malandrinum 100X
Carcinosin 100X, 200X
Arsenicum album 200X
Petroleum 200X
Sulphur 200X
Questions
Professional Formulas
PO Box 2034 Lake Oswego, OR 97035
Indications
For the temporary relief of fatigue, insomnia, sinusitis or other upper respiratory allergies, or suppression of emotions consistent with classical carcinosin miasm.*
Otc - Purpose
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Warnings
In case of overdose, get medical help or contact a poison control center right away.
Otc - Keep Out Of Reach Of Children
Keep out of the reach of children.
Otc - Pregnancy Or Breast Feeding
If pregnant or breastfeeding, ask a healthcare professional before use.
Directions
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Other Information
Tamper resistant. If seal is broken, do not use. After opening, close container tightly and store at room temperature away from heat.
Inactive Ingredients
20% ethanol, purified water.
Label
Est 1985
Professional Formulas
Complementary Health
Carcinosin Miasm Drops
Homeopathic Remedy
2 FL. OZ. (59 mL)
* Please review the disclaimer below.